Semi-Annual Statement Of Income And Retained Earnings

BrightPath Biotherapeutics Co., Ltd. - Filing #7257216

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-1,160,918,000 JPY
-1,155,078,000 JPY
Non-operating income
Non-operating income
17,428,000 JPY
299,000 JPY
Non-operating expenses
Non-operating expenses
4,388,000 JPY
4,149,000 JPY
Ordinary profit (loss)
-1,147,879,000 JPY
-1,158,929,000 JPY
Extraordinary losses
Extraordinary losses
1,370,000 JPY
7,252,000 JPY
Profit (loss) before income taxes
-1,149,249,000 JPY
-1,166,182,000 JPY
Income taxes - current
1,900,000 JPY
1,900,000 JPY
Profit (loss)
-1,151,149,000 JPY
-1,151,149,000 JPY
-1,151,149,000 JPY
-1,151,149,000 JPY
-1,168,082,000 JPY
-1,168,082,000 JPY
-1,168,082,000 JPY
-1,168,082,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.